MArcila

[MArcila @MEArcila]

@SeanLachhander Amazing! my best wishes to you both.

[MArcila @MEArcila]

Featured today by @MSKLibrary: Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therap... https://t.co/YAgt2LDF84

[MArcila @MEArcila]

Featured today by @MSKLibrary: Molecular Pathology Education: A Suggested Framework for Primary Care Resident Training in Genomi... https://t.co/4nQ8fK4dao

[MArcila @MEArcila]

@CancerCytopath Yes - very feasible. We recently also published our experience with 300+ cytology samples - outlining that with proper handling, these samples are sufficient for ultra-rapid mutation screening and reflex comprehensive NGS.

[Jackie Hechtman @JackieHechtman]

Testing for kinase fusions is of particular value after resistance to endocrine therapy emerges if ESR1 is wild type as it opens another avenue for treatment. We did find (rare) kinase fusions in endocrine therapy- naive tumors as well!